People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cleerly, Inc. | — | Other Technology | Series D+ | $274.9M | $535.8M | 2022 |
| Vertiflex, Inc. | — | Other Health Care | Series C | $134.1M | $1.0B | 2010 |
| ChromaCode, Inc. | — | Biotechnology | Series B | $94.2M | $21.4M | 2017 |
| VytronUS Inc | — | Other Health Care | Series B | $91.1M | $664.6M | 2009 |
| Intact Vascular, Inc. | — | Other Health Care | Series B | $86.8M | $299.1M | 2020 |
| Senseonics, Inc | — | Biotechnology | Series B | $60.8M | $396.9M | 2014 |
| Senseonics Holdings, Inc. | — | Biotechnology | Series B | $39.3M | $98.9M | 2020 |
Peter Justin Klein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Justin Klein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.